Diabetes

October 8, 2017

Natural product-based therapy for Metabolic diseases: Kavin, isolated from Kava Kava/Piper Methysticum, increases the expression of Caveolin-1, stabilizes insulin receptor, promotes insulin sensitivity, incrases vasorelaxation, and decreases the risk of hyperglycemia and TIIDM via up regulation of its target gene.., 09/October/2017, 1.11 am

Introduction: What they say A study from the Institute for Molecular Systems Biology, ETH Zurich, Zurich, Switzerland shows that “MicroRNAs 103 and 107 regulate insulin sensitivity.” This study was published, in the June […]
October 6, 2017

Natural product-based therapy for TIIDM: A pharmaceutical mixture encompassing Luteolin, Apogenin, Formononetin, Isoliquiritigenin , and Gallic acid (LAFIG) augments the expression of FGF19 and FGF1,   attenuates hepatic glucose production, decreases hepatic acetyl CoA content, brings down the levels of plasma ACTH, and corticosterone, augments insulin sensitivity, promotes weight loss and alleviates TIIDM via up regulation of its target gene, 6/October/2017, 11.51 pm

Introduction: What they say A study from Diabetes and Obesity Center of Excellence, Department of Medicine, University of Washington, Seattle, Washington, USA shows that Central injection […]
October 5, 2017

Natural product-derived regenerative therapy for reversing diabetes: A pharmaceutical mixture encompassing Celastrol, Mangiferin, Omega-3, Taurine, & Vit-D/C/E (CMOTV-DCE) increases the expression of Sox17, Sox2, Pdx-1, and Ngn3, decreases mTOR expression, promotes regeneration of insulin-producing ß cells, increases insulin secretion, promotes glucose homeostasis and reverses T1D and T2D via down regulation of its target gene, 6/October/2017, 1.27 am

Introduction: What they say A study from the Longevity Institute, School of Gerontology, Department of Biological Sciences, University of Southern California, 3715 McClintock Avenue, Los Angeles, […]
October 5, 2017

Small molecule-based therapy for TIIDM, Metabolic defects and Longevity: L-deprenyl,  used in the treatment of Parkinson’s disease and depression, increases Sirtuin-4 expression, augments insulin secretion, reduces metabolic stress, improves glucose uptake, promotes glucose homeostasis and prevents progression to TIIDM via down regulation of its target gene, 06/October/2017, 12.49 am

Introduction: What they say A study from the “Duke Molecular Physiology Institute and Sarah W. Stedman Nutrition and Metabolism Center, Duke University Medical Center, Durham, NC […]